Showing results (921-930 of 1,990) with videos related to

Sort By:
Pageof 199
Prostate Cancer and Prostatic Diseases|June 20, 2012
Evaluating prostate cancer mortality and competing risks of death in patients with localized prostate cancer using a comprehensive nomogramA Kutikov, M R Cooperberg, A T Paciorek, et al.
Prostate Cancer and Prostatic Diseases|July 11, 2012
Does variation in either age at start of therapy or duration of therapy make chemoprevention with finasteride cost-effective?S B Stewart, C D Scales, J W Moul, et al.
Prostate Cancer and Prostatic Diseases|February 4, 2010
A retrospective analysis illustrating the substantial clinical and economic burden of prostate cancerE D Crawford, L Black, M Eaddy, et al.
Prostate Cancer and Prostatic Diseases|September 15, 2018
Importance of androgen-deprivation therapy during enzalutamide treatment in men with metastatic castration-resistant prostate cancer following chemotherapy: results from retrospective, multicenter dataChang Wook Jeong, Minyong Kang, Seung Il Jung, et al.
Prostate Cancer and Prostatic Diseases|October 1, 2021
Predicting high-grade prostate cancer at initial biopsy: clinical performance of the ExoDx (EPI) Prostate Intelliscore test in three independent prospective studiesErik Margolis, Gordon Brown, Alan Partin, et al.
Prostate Cancer and Prostatic Diseases|October 14, 2021
Characterization of a castrate-resistant prostate cancer xenograft derived from a patient of West African ancestryBrendon M Patierno, Wen-Chi Foo, Tyler Allen, et al.
Prostate Cancer and Prostatic Diseases|July 9, 2022
Clinical use of the mRNA urinary biomarker SelectMDx test for prostate cancerWieke C H Visser, Hans de Jong, Sandra Steyaert, et al.
Prostate Cancer and Prostatic Diseases|April 13, 2023
Health-related quality of life in patients with metastatic hormone-sensitive prostate cancer treated with androgen receptor signaling inhibitors: the role of combination treatment therapyLuca Afferi, Mattia Longoni, Marco Moschini, et al.
Prostate Cancer and Prostatic Diseases|April 1, 2021
Prostate cancer prognosis after initiation of androgen deprivation therapy among statin users. A population-based cohort studyA I Peltomaa, P Raittinen, K Talala, et al.
Prostate Cancer and Prostatic Diseases|May 5, 2023
PCPro: a clinically accessible, circulating lipid biomarker signature for poor-prognosis metastatic prostate cancerTahlia Scheinberg, Hui-Ming Lin, Michael Fitzpatrick, et al.
Pageof 199